Clinical trial
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in…
NCT00250601 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00250601 |
|---|---|
| Title | An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression |
| Official title | An Eight-Week, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | Saredutant succinate (SR48968C) |
| Enrollment | 460 |
| Start date | Apr 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Nov 8, 2005 |
| Last update posted | Feb 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: